cytosolic 5'-nucleotidase 1A (NT5C1A) in serum
Jump to navigation
Jump to search
Indications
- evaluation of inclusion body myositis
Clinical significance
- associated with inclusion body myositis (61%)[2]
- also found in patients with systemic lupus erythematosus (14%), systemic sclerosis (23%), dermatomyositis (15%) & healthy individals (5%)[2]
More general terms
Additional terms
References
- ↑ Greenberg SA. Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility. Muscle Nerve. 2014 Oct;50(4):488-92. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24752512
- ↑ 2.0 2.1 2.2 Lloyd TE, Christopher-Stine L, Pinal-Fernandez I et al Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases. Arthritis Care Res (Hoboken). 2016 Jan;68(1):66-71. PMID: https://www.ncbi.nlm.nih.gov/pubmed/25892010 Free PMC Article